Phase 3 Parkinson’s Disease Study

Now Open in Savannah

Now Enrolling

About This Research Study

Parkinson’s Disease (PD) causes a breakdown of motor function over time, causing a loss of coordination, tremors, shakes, and more. Meridian is enrolling adults recently diagnosed with PD for a clinical trial of an investigational medication for the disease.

Eligible participants…

  • Must be age 40 to 80
  • Must have early PD, and have been diagnosed with PD within the past 3 years
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.

Expect Excellence icon - supporting research since 1999

Submit your information

Study Location

Meridian Clinical Research
6602 Waters Avenue, Building C
Savannah, GA 31406

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.